Specific barriers to the conduct of randomized trials

Clinical Trials

Volumn 5, Issue 1, 2008, Pages 40-48

  Duley, Lelia ^a   Antman, Karen ^b   Arena, Joseph ^c   Avezum, Alvaro ^d   Blumenthal, Mel ^e   Bosch, Jackie ^f   Chrolavicius, Sue ^f   Li, Timoa ^g   Ounpuu, Stephanie ^h   Perez, Analia Cristina ⁱ   Sleight, Peter ^j   Svard, Robbyna ^k   Temple, Robert ^l   Tsouderous, Yannis ^m   Yunis, Carla ⁿ   Yusuf, Salim ^f  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^e BRISTOL MYERS SQUIBB   (United States)

^f MCMASTER UNIVERSITY   (Canada)

^g HEALTH CANADA   (Canada)

^h Boehringer Ingelheim   (Canada)

ⁱ ANMAT   (Argentina)

^j UNIVERSITY OF OXFORD   (United Kingdom)

^k Boehringer Ingelheim   (Sweden)

^l CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^m Servier ^*  (France)

ⁿ PFIZER INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; AWARENESS; BUILDING; CLINICAL PRACTICE; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DOCUMENTATION; DRUG MONITORING; DRUG RESEARCH; DRUG SAFETY; DRUG USE; FUNDING; KNOWLEDGE; LOWEST INCOME GROUP; MEDICAL EDUCATION; MEDICAL ETHICS; METHODOLOGY; MULTICENTER STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZATION; SIDE EFFECT; SOCIOECONOMICS; TRAINING;

CONFIDENTIALITY; CONSENT FORMS; ETHICS COMMITTEES; HUMANS; MULTICENTER STUDIES AS TOPIC; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 40949108412     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774507087704     Document Type: Conference Paper

References (22)

1. Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials? Stat Med 1984; 3: 409-20.
2. Collins RMS. Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials. Lancet 2001; 357: 373-80.
3. Briggs A. Economic evaluation and clinical trials: size matters. BMJ 2000; 321: 136-3.
4. Warlow C. Advanced issues in the design and conduct of randomized clinical trials: the bigger the better? Statistics in Medicine 2002; 21: 2797-805.
5. ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988; 2: 349-60.
6. CRASH Trial Collaborators. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 2004; 364: 1321-8.
7. Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002; 359: 1877-90.
8. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 23-33.
9. Heart Outcomes Prevention Evaluation Trial Investigators. Effects of angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med 2000; 342(3): 145-53.
10. Watson R. EU legislation threatens clinical trials. BMJ 2003; 326: 1348-134a.
11. Hemminki A, Kellokumpu-Lehtinen PL. Harmful impact of EU clinical trials directive. BMJ 2006; 332: 501-2.
12. Mitchell CD. Harmful impact of EU clinical trials directive:...while paediatric oncology is being scuppered. BMJ 2006; 332: 666.
13. Hanning CD, Rentowl P. Harmful impact of EU clinical trials directive: trial of alerting drug in fibromyalgia has had to be abandoned. BMJ 2006; 332: 666.
14. Watson M. Harmful impact of EU clinical trials directive:...and so has trial of melatonin in cancer related weight loss. BMJ 2006; 332: 666.
15. Bosch X. Europe's restrictive rules strangling clinical research. Nature Medicine [NLM - MEDLINE] 2005; 11: 1260.
16. Hearn J, Sullivan R. The impact of the 'Clinical Trials' directive on the cost and conduct of non-commercial cancer trials in the UK. European Journal of Cancer 2007; 43: 8-13.
17. Chalmers I, Rounding C, Lock K. Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002. BMJ 2003; 327: 1017.
18. Hartmann M, Hartmann-Vareilles F. The clinical trials directive: How is it affecting Europe's noncommercial research? PLoS Clin Trials 2006; 1: e13.
19. Warlow C. Clinical trials for tomorrow funded by the MRC. BMJ 2003; 327: 240-1.
20. Bell J. Resuscitating clinical research in the United Kingdom. BMJ 2003; 327: 1041-3.
21. Prescott RJ, Counsell CE, Gillespie WJ, et al. Factors that limit the quality, number and progress of randomised controlled trials. Health Technol Assess 1999; 3: 1-143.
22. Sustainable Trials Study Group. Towards sustainable clinical trials. BMJ 2007; 334: 671-3.